Full Text View
Tabular View
No Study Results Posted
Related Studies
The Effectiveness of Two Osteoporosis Drugs on Prosthetic Bone Mineral Density (BMD) Loss After Total Hip Arthroplasty(THA) (ETOD)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2009 by Yokohama City University Medical Center.
Recruitment status was  Active, not recruiting
Study NCT01020253   Information provided by Yokohama City University Medical Center

First Received on November 24, 2009.   Last Updated on December 2, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bone Density
Arthroplasty, Replacement, Hip
Interventions listed in this trial
alendronate, alfacalcidol
Additional drug interventions recognized in this trial
1-hydroxycholecalciferol
Alendronate
Hydroxycholecalciferols
More general drug interventions related to this trial
Bone Density Conservation Agents
Growth Substances
Micronutrients
Pharmacologic Actions
Physiological Effects of Drugs
Vitamins
Sponsors listed in this trial
Yokohama City University Medical Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services